I'm back from last week's Built with Biology conference.

Here's a few key takeaways from people I saw on stage and spoke to.

I was lucky enough to attend this year's Ginkgo Ferment Summit at the end of October 2021. Because of the pandemic, this was the first time in two years that Ginkgo Bioworks held the event. Here are a few learnings.

Once you’ve engineered your microorganism to produce your billion-dollar molecule, how are you going to scale up production?

In 2020, A16Z’s Vijay Pande and Judy Savitskay wrote a paper called, The Biggest Open Opportunity in Synthetic Biology, listing out the need for novel bio-manufacturing platforms.

Last month, Boston Consulting Group and Hello Tomorrow released a report called Nature Co-Design: A Revolution in the Making, exploring the impact of harnessing nature's design principles, applying deep tech's Design-Build-Test-Learn cycle, and its economic implications.

Messaginglab CEO and WHAT'S YOUR BIO-STRATEGY? PREPARING YOUR BUSINESS FOR SYNTHETIC BIOLOGY co-author, Karl Schmieder, will be hosting a panel at Ginkgo Bioworks on Monday, May 6th in Boston.

While the term “thought leader” may be overused in PR and marketing circles, the need for thought leadership continues to grow as consumers are overwhelmed by too much noise and too many choices. This is especially true in the life sciences where topics remain unfamiliar to most, while the impact on our lives significantly increases every day.

Captain Underpants is not a name generally associated with biotechnology. Yet, this wildly successful (70 million copies sold worldwide) series of children’s novels may be the first exposure many children have to biotech. Probably, it won’t be their last.